"Mr. Reyes…what''s the situation?" Juliet arrived promptly from the emergency call from Michael.
"Juliet…read this article," Michael said, handing her his tablet.
Juliet took the tablet and scanned the article, her eyes narrowing as she digested the information. "This new regtion from China... it''s directly targeting foreign srpanies, isn''t it?"
"Yes, it seems they''re putting barriers specifically to keep us out," Michael replied, his voiceced with frustration. "I suspect JinkoSr is behind this. They''re pushing to eliminatepetition in their home market."
"We need to act fast," Juliet suggested. "We should consult our legal team to challenge these regtions. There might be a way to contest this through international tradews."
"But that is too much of a hassle," Michael said and then remembered something. "Wait…isn''t our target China? China has arger market for sr panels than America, and we need to prate their market to achieve our global expansion goals. What if we use internationalw to our advantage? Can we challenge these regtions in the World Trade Organization?"
Juliet nodded thoughtfully. "That''s a valid point, Mr. Reyes. The WTO has mechanisms for resolving trade disputes. If these regtions vite international trade agreements, we could file aint. It would put pressure on China to justify their actions under global trade norms."
Michael leaned back in his chair, contemting the strategy. "That could also bring international attention to the issue. If we frame it as a fight for fair trade and innovation, it could garner support from other markets and stakeholders. So, Juliet, you know what to do with these."
"I''ll have it researched right away."
With that, Juliet exited Michael''s office and headed to her office. She quickly opened her monitor and then started researching how to file a protest to the WTO against China''s recent trade policy.
She found that the process involved several steps, starting with a consultation phase where theining party formally requests consultations with the other party to try to resolve the dispute amicably.
Juliet took meticulous notes on the requirements: theint must be written and provide specific details of the measures in question and the legal basis for theint, referencing specific agreements andmitments under the WTO framework.
She then learned that if consultations failed to resolve the dispute within 60 days, theinant could request the establishment of a panel. This panel,posed of three or more experts in tradew and policy, would examine the case, consider the arguments of both sides and issue a report detailing its findings and rmendations.
Juliet''s screen was filled with tabs on WTO procedures, legal precedents, and case studies of simr disputes. She started drafting a document outlining the initial steps SraTech needed to take, including gatheringprehensive data on how China''s new regtions affected their business and potentially vited specificmitments under the WTO''s legal framework.
Three hourster, shepiled a preliminary action n. This document outlined the stages of theint process, necessary documentation, and the timeline for each phase.
It also included potential arguments they could use to demonstrate how China''s regtions were disproportionately affecting SraTech and possibly viting the General Agreement on Tariffs and Trade (GATT) principles, particrly those rted to nondiscrimination and market ess.
Juliet knew the importance of building a strong case supported by data and precedent. She nned to gather evidence of how the new regtions specifically targeted foreignpanies like SraTech, impacting their market ess and creating an unfairpetitive advantage for Chinesepanies.
Her next step was to coordinate with SraTech''s legal department to refine the draft, ensuring every argument was legally sound and backed by substantial evidence. She also noted the need to consult with international tradew experts who could provide insight into the likelihood of sess and potential challenges they might face during the dispute process.
***
Meanwhile, while Juleit was busying herself with her work, Michael on the other hand received a new notification from the system.
[New Mission Unlocked: Establish New Enterprise: Depending on your main enterprise, the photovoltaicpany, wouldn''t lead you to build a business empire if the product you are selling is being blocked by the world''srgest market share in sr panels. Your mission is to start anotherpany that is as lucrativeas your sr panels.]
[Suggestion: You could start with the one in your mind, a pharmaceuticalpany. Compared to the photovoltaicpany, which is a luxury for the masses to afford, a pharmaceuticalpany is a necessity. Medicines are essential, and the demand is always there, irrespective of economic conditions.
This could be your way to diversify and strengthen your business portfolio, ensuring stability and consistent growth.
Plus, with the ongoing global health challenges, there''s a clear and immediate need for innovative pharmaceutical solutions. You can leverage the research and development capabilities of your sr panel enterprise to innovate in the pharmaceutical sector, perhaps focusing on sustainable and environmentally friendly production methods.
This new venture could also open doors to markets that are less susceptible to the kind of political and trade pressures you''re facing with the sr panel business.]
[Rewards: 200,000 System Points]
Michael read that long text and nodded in understanding. The system was right, he couldn''t just have it all depend on photovoltaic energy alone. The pharmaceutical industry presented a new arena with its challenges and opportunities. He had to think about the long-term viability of his business empire.
"Pharmaceuticals, huh?" he murmured to himself, considering the shift. "I have nned it long ago to bring down thepany my father has built. He left us and I will make sure to destroy his legacy."
The one he had in mind was apany that would do the impossible, a cure for cancer. Now there is no cure for cancer as of yet. The reason for this is that there are too many variants of the disease, and it adapts quickly to new treatments. Fortunately, he has the technological system in his possession.
That is settled, Michael is going to establish a new enterprise, a pharmaceuticalpany. It''s going to be exhrating, he already wondered what the reaction of the public and pharmaceutical giants would be if such a cure is found.